The invention relates to a substantially pure polypeptide functioning as
an ASIC1a channel blocker. Also provided is a nucleic acid molecule
coding such polypeptide, pharmaceutical composition containing such
polypeptide and a method of manufacturing an ASIC1a channel blocker.